We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$8.34M
Cap. Flow
-$2.14M
Cap. Flow %
-0.89%
Top 10 Hldgs %
31.13%
Holding
156
New
16
Increased
22
Reduced
90
Closed
5
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.17M
2
ABT icon
Abbott
ABT
+$1.04M
3
TGT icon
Target
TGT
+$910K
4
XYL icon
Xylem
XYL
+$837K
5
XLNX
Xilinx Inc
XLNX
+$764K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$4.32M
2
ILMN icon
Illumina
ILMN
+$1.7M
3
PEP icon
PepsiCo
PEP
+$1.4M
4
NXPI icon
NXP Semiconductors
NXPI
+$668K
5
CVS icon
CVS Health
CVS
+$600K

Sector Composition

Rank Sector Weight
1 Technology 24.27%
2 Healthcare 21.64%
3 Industrials 17.46%
4 Energy 11.72%
5 Miscellaneous 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.13T
$684K 0.29%
5,400
– –
2013 Q2
4 quarters
IONS icon
52
Ionis Pharmaceuticals
IONS
$7.1B
$648K 0.27%
+18,810
New +$592K
2014 Q2
0 quarters
NSC icon
53
Norfolk Southern
NSC
$72.7B
$618K 0.26%
6,000
– –
2013 Q2
4 quarters
WMT icon
54
Walmart Inc
WMT
$922B
$597K 0.25%
23,847
– –
2013 Q2
4 quarters
NVO icon
55
Novo Nordisk
NVO
$168B
$589K 0.25%
25,500
-3,000
-11% -$66.2K
2013 Q2
4 quarters
COP icon
56
ConocoPhillips
COP
$171B
$507K 0.21%
5,905
-30
-0.5% -$2.34K
2013 Q2
4 quarters
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$30B
$495K 0.21%
7,840
+150
+2% +$8.92K
2013 Q2
4 quarters
DE icon
58
Deere & Co
DE
$175B
$489K 0.2%
5,400
-2,000
-27% -$184K
2013 Q2
4 quarters
BMY icon
59
Bristol-Myers Squibb
BMY
$121B
$484K 0.2%
9,982
-25
-0.2% -$1.23K
2013 Q2
4 quarters
COST icon
60
Costco
COST
$435B
$446K 0.19%
3,873
-433
-10% -$49.7K
2013 Q2
4 quarters
RPM icon
61
RPM International
RPM
$12.5B
$432K 0.18%
9,354
-541
-5% -$23.4K
2013 Q2
4 quarters
STT icon
62
State Street
STT
$45.8B
$419K 0.17%
6,210
– –
2013 Q2
4 quarters
NBL
63
DELISTED
Noble Energy, Inc.
NBL
$406K 0.17%
5,238
-382
-7% -$27.8K
2013 Q2
4 quarters
STKL
64
DELISTED
SunOpta
STKL
$404K 0.17%
+28,700
New +$356K
2014 Q2
0 quarters
GPC icon
65
Genuine Parts
GPC
$18.1B
$396K 0.17%
4,507
-258
-5% -$22.2K
2013 Q2
4 quarters
HES icon
66
DELISTED
Hess
HES
$396K 0.17%
4,000
– –
2013 Q2
4 quarters
JPM icon
67
JPMorgan Chase
JPM
$890B
$379K 0.16%
6,574
-55
-0.8% -$3.09K
2013 Q2
4 quarters
SJM icon
68
J.M. Smucker
SJM
$13B
$371K 0.15%
3,480
-50
-1% -$5.02K
2013 Q2
4 quarters
CYN icon
69
DELISTED
CITY NATIONAL CORPORATION
CYN
$352K 0.15%
4,650
+750
+19% +$55.6K
2014 Q1
1 quarter
ANSS icon
70
DELISTED
Ansys
ANSS
$350K 0.15%
4,617
-258
-5% -$19.4K
2013 Q2
4 quarters
PCP
71
DELISTED
PRECISION CASTPARTS CORP
PCP
$344K 0.14%
1,364
-86
-6% -$22K
2013 Q2
4 quarters
LECO icon
72
Lincoln Electric
LECO
$14.1B
$335K 0.14%
4,801
-289
-6% -$19.6K
2013 Q2
4 quarters
GLW icon
73
Corning
GLW
$121B
$329K 0.14%
14,980
-9,650
-39% -$205K
2013 Q2
4 quarters
CTSH icon
74
Cognizant
CTSH
$28.1B
$326K 0.14%
6,665
-605
-8% -$29.5K
2013 Q2
4 quarters
TROW icon
75
T. Rowe Price
TROW
$21.3B
$311K 0.13%
3,690
-35
-0.9% -$2.86K
2013 Q2
4 quarters
1 2
3
4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q2 2014 Portfolio in Review

As of Q2 2014, Michael B. Elefante held 156 positions worth $240M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael B. Elefante's Q2 2014 filing shows 16 new, 22 increased, 90 reduced and 5 closed positions. Its largest new stake was Xylem: 22,405 shares worth $875K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $4.32M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Michael B. Elefante's largest Q2 2014 buy was Xylem: 22,405 shares worth $875K.
  • Michael B. Elefante added most to Qualcomm in Q2 2014, an estimated $1.17M increase.
  • Michael B. Elefante's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $4.32M.
  • Michael B. Elefante fully exited Aflac in Q2 2014, selling an estimated $91K.
  • Michael B. Elefante's ten largest holdings make up 31% of its $240M portfolio in Q2 2014.
  • Michael B. Elefante opened 16 new positions and closed 5 in Q2 2014.
  • Michael B. Elefante's portfolio value rose 3.6% quarter-over-quarter to $240M.

Based on Michael B. Elefante's 13F filing for Q2 2014, filed 24 Jul 2014.